期刊文献+

复发性卵巢上皮性癌的诊断及处理 被引量:2

Diagnosis and treatment of recurrent epithelial ovarian carcinoma
原文传递
导出
摘要 目的 探讨复发性卵巢上皮性癌的诊断、治疗方法及其预后。方法 将 5 2例复发性卵巢上皮性癌患者分为 5组 ,手术 +化学药物治疗 (化疗 )组 ,共 2 6例 ;单纯化疗组 ,共 14例 ;手术 +化疗 +放射治疗 (放疗 )组 ,共 4例 ;手术 +放疗组 ,共 4例 ;未治组 :4例。对复发性卵巢上皮性癌的诊断方法和各组间生存时间进行比较。结果 复发性卵巢上皮性癌的诊断方法其阳性诊断率依次为 ,妇科检查 (妇检 ) 73 1% ,B超 84 6 % ,CA12 55 3 8% ,妇检、B超和CA12 5联合检测阳性率为 70 5 %。手术 +化疗组、单纯化疗组的中位数生存时间分别为 11个月和 12个月。手术 +化疗 +放疗组的生存时间为 10~ 12个月。手术 +放疗组的生存时间为 14~ 2 5个月。结论 妇检、B超和CA12 5的联合检测有助于提高复发性卵巢上皮性癌的诊断阳性率。在复发性卵巢上皮性癌治疗中 ,手术的作用有待进一步研究证实 ,化疗具有很好的作用 ,放疗的作用和地位应引起注意。 Objective To investigate the diagnosis,treatment and prognosis of recurrent epithelial ovarian carcinoma. Methods Fifty-two patients with recurrent epithelial ovarian carcinoma who were admitted in Zhongnan Hospital of Wuhan University between 1997 and 2002 were analyzed retrospectively,and their diagnostic methods and the survival rates were compared. Results The positive diagnostic rate of pelvic examination,CA 125 and ultrasound examination was 73.1%,84.6% and 53.8%,respectively to the recurrent epithelial ovarian carcinoma. The median survival time of group A(surgery+chemotherapy) and group B ( chemotherapy) was 11 and 12 months,respectively. Conclusions The diagnostic methods should include pelvic examination,CA 125 and ultrasound examination. We could not know the exact role of surgery to the management and prognosis of recurrent epithelial ovarian carcinoma. Chemotherapy may have an important role to the management and prognosis of recurrent epithelial ovarian carcinoma.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2003年第11期664-666,共3页 Chinese Journal of Obstetrics and Gynecology
关键词 复发性卵巢上皮性癌 诊断 治疗 预后 手术疗法 化学疗法 Neoplasm recurrence,local Ovarian neoplasms Carcinoma Diagnosis Therapy
  • 相关文献

参考文献1

  • 1张帆 陈惠祯 谭道彩 吴绪峰 主编.卵巢癌治疗后的监测[A].陈惠祯,谭道彩,吴绪峰,主编.现代妇科肿瘤治疗学:第2版[C].武汉:湖北省科技出版社,2001.314-332.

同被引文献29

  • 1李孟达,李玉洁,黄永文,黄鹤.影响上皮性卵巢癌远期疗效的因素分析[J].癌症,2004,23(11):1306-1310. 被引量:19
  • 2曹泽毅,于莎莎.妇科恶性肿瘤治疗后一年内未控与复发原因的研究——附全国61所医院1753例分析[J].中华妇产科杂志,1996,31(7):417-421. 被引量:21
  • 3程燕,宁刚,宋彬,朱慧莉,赵福敏,鲍莉,罗小华.卵巢癌术后复发及腹膜转移的多排螺旋CT表现及其与血清CA125的关系[J].四川大学学报(医学版),2007,38(4):736-738. 被引量:7
  • 4Eisenkop SM, Friendman RL, Wang HJ . Secondary cytoreductive surgery for recurrent ovarian cancer. Cancer,1995,76(9):1606-1614
  • 5Bristow RE, Lagasse LD,Karian BY.Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Cancer , 1996,78(10):2049-2061
  • 6吕雯 钱文淑 楼洪坤.复发卵巢上皮癌二次细胞减灭术意义及疗效影响因素[A]..中国抗癌协会妇科肿瘤专业委员会第六次全国学术会议[C].沈阳,2001..
  • 7Morris M, Gershenson DM, Wharton JT,et al. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol,1989,34(3)334-338
  • 8Segna RA, Dottino PR, Mondeli JP,et al .Secondary cytoreduction for ovarian cancer following cisplatin therapy.J Clin Oncol ,1993,11(3):434-439
  • 9Vaccarello L,Rubin SC,Vlamis V, et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response .Gynecol Oncol, 1995,57(1):61-65
  • 10CHANG X, YE X, DONG L, et al. Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma [ J ] . Int J Gynecol Cancer, 2011, 21(05): 852- 858.

引证文献2

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部